Tetherex Pharmaceuticals is an Oklahoma City-based biotechnology company founded in 2014. Specializing in the healthcare industry, the company is focused on pioneering the future of biotechnology to enhance global health. With its most recent $50.00M Series B investment secured on 18 April 2018, Tetherex Pharmaceuticals has attracted investment from prominent firms such as MPM Capital and Phil Jones. The company's dedication to advancing biotechnology in the realms of health care and pharmaceuticals underscores its commitment to innovation and global health enhancement.
No recent news or press coverage available for Tetherex Pharmaceuticals.